Select Language:
Digital Phablet – Test Results Reveal Details for Celebrities
The publicly released test results involve actors Hande Erçel, İbrahim Çelikkol, İlkay Şencan, and Deha Bilimlier, who were questioned as part of a celebrity narcotics investigation. While some individuals’ blood samples showed no traces of drugs, hair analyses indicated the presence of cocaine, codeine, and THC (tetrahydrocannabinol) metabolites. The list of names includes the following:
The investigation, overseen by the Istanbul Anatolian Chief Public Prosecutor’s Office in conjunction with the Istanbul Provincial Gendarmerie Narcotics Crimes Branch, targeted notable figures suspected of involvement in supplying and possessing narcotic or stimulant substances for personal use. Arrest warrants had been issued for those identified.
Latest Findings from Laboratory Tests
Initial results for Hande Erçel, İbrahim Çelikkol, İlkay Şencan, Hakan Sabancı, Fikret Orman, and Deha Bilimlier were disclosed. Notably, Hande Erçel’s blood sample was free of any drugs or steroids.
According to the examination, her urine contained morphine, codeine, and its metabolite, codeine glucuronide. Paracetamol, a common pharmaceutical, was also detected. However, her hair analysis revealed no signs of illicit substances or stimulants. Her nail sample was deemed unreadable due to being coated with permanent polish and thus was not analyzed.

Further tests showed that Mustafa Ceceli’s blood was drug-free. Meanwhile, cocaine and its byproducts, benzoylecgonine and methylecgonine, were found in his hair sample; nail testing was not possible.
Similarly, İbrahim Çelikkol’s hair sample tested positive for cocaine and related substances. Deha Bilimlier’s hair analysis revealed the presence of codeine, cocaine, and their metabolic byproducts. Moreover, THC-COOH, a metabolite of THC—the psychoactive component in cannabis—was identified in İlkay Şencan’s blood, with THC itself detected in her hair sample.
Additional Surveillance Footage
Watch the related Facebook video here
This ongoing investigation paints a detailed picture of substance testing among high-profile individuals, highlighting the complexities and challenges in such disclosures.





